McIntosh/Shays hearing on FDA device program slated for June 29.
This article was originally published in The Gray Sheet
MCINTOSH/SHAYS HEARING ON FDA DEVICE PROGRAM SLATED FOR JUNE 29, according to staffers. Both Congressmen serve on the House Government Reform and Oversight Committee, with Rep. David McIntosh (R-Ind.) chairing the National Economic Growth Subcommittee, and Rep. Christopher Shays (R-Conn.) heading up the Human Resources Subcommittee. Specific elements of the device program to be examined at the joint subcommittee hearing have not yet been determined, staffers say, and witnesses have not yet been scheduled.
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.